Engagement and symptom support for newly diagnosed acute leukemia
Part of Cancer clinical trials.
This trial tests an emotion- and symptom-focused way of engaging with care for people who are newly diagnosed with acute leukemia and starting intensive “induction” treatment aimed at cure. It may help you feel better supported and better able to manage distressing symptoms during a critical early phase of treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (age 18 or older) with newly diagnosed acute leukemia (AML or ALL, or other specified acute leukemia types).
- You are being recruited very early—up to 1 week before hospital admission or within 2 weeks after admission.
- You are starting (or expected to start) induction treatment intended to cure your disease.
- You can complete brief cognitive screening and answer questionnaires in English (you must be willing, not just able).
- You should not have major communication problems that prevent you from participating (like severe hearing issues or not being able to speak).
- You cannot currently be receiving in-hospital psychological/psychiatric counseling or in-hospital palliative (comfort-focused) care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a formal support program can help people newly diagnosed with acute leukemia. If you're starting treatment at the Centre Henri Becquerel, this program may offer extra guidance and help improve your quality of life.
This study is beta-testing a new app designed to reduce healthcare disparities among people admitted to the hospital with suspected acute leukemia. Your feedback could help make the app more helpful for future patients.
This trial studies how screening for social needs (like housing, food, or transportation) and offering early help can improve care for adults with leukemia. It is for patients newly referred to a leukemia clinic.
This study tests whether adding spiritual care to standard treatment helps adults newly diagnosed with acute leukemia feel better emotionally and spiritually. You may join if you are starting your first hospital treatment for AML or ALL.
This trial tests how safe and tolerable LBS-007 is for adults with AML or ALL that has come back or is resistant to treatment. It may help people who can’t use standard therapies or have no proven treatment options.
This study tests an approach to help people with certain blood cancers and their main caregiver plan ahead and communicate more clearly about end-of-life care. It may help patients feel more supported and better prepared for difficult decisions.
Hear when a new Acute Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.